Asociación Española Cáncer de Mama Metastásico shared a post on LinkedIn:
“For years, innovation in oncology has been mainly associated with new treatments, therapies or technologies.
However, more and more international experts are promoting a complementary reflection: Does everything we can do in oncology really bring benefit to patients?
Because in some cases more treatment does not always mean more benefit.
It may involve:
- Significant side effects
- tests or interventions with limited impact
- Clinical decisions that do not always take into account quality of life.
The Common Sense Oncology approach proposes precisely to open this debate and move towards an oncology that combines scientific evidence, clinical criteria and the real experience of patients.
On March 19 in Madrid, from the Asociación Española Cáncer de Mama Metastásico together with ecancer we organize a conference dedicated to this approach.
The meeting will feature specialists such as the oncologist Enrique Soto Perez de Celis, a researcher at the University of Colorado Anschutz, and the oncologist Sara Lopez-Tarruella from the Hospital Gregorio Marañón, among other professionals who will participate in this multidisciplinary dialogue.
A space for dialogue aimed at healthcare professionals, researchers and patients to reflect on a key issue:
- How to make clinical decisions that provide real benefit to people living with metastatic breast cancer.
Because innovating in oncology is not just about doing more.
It is also about knowing when, how, and for whom it makes sense to do it.
- More information and registration in the first comment.”
